PP
NVO

PDT Partners’s Novo Nordisk NVO Stock Holding History

PDT Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-136,192
Closed -$3.73M – 1471
2015
Q2 		$3.73M Buy
+136,192
New +$3.83M 0.1% 261
2014
Q3 		– Sell
-16,882
Closed -$390K – 1498
2014
Q2 		$390K Buy
+16,882
New +$373K 0.01% 1108
2013
Q4 		– Sell
-50,540
Closed -$855K – 1005
2013
Q3 		$855K Buy
+50,540
New +$850K 0.02% 826

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

PDT Partners's NVO Position: Q3 2015 in Review

PDT Partners sold out of Novo Nordisk (NVO) in Q3 2015, closing a stake of 136,192 shares — an estimated $3.73M sold.

PDT Partners first reported a position in NVO in Q3 2013 and held it in 3 quarters. The position peaked at $3.73M in Q2 2015. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

  • PDT Partners reported no remaining Novo Nordisk position as of Q3 2015 after selling out during the quarter.
  • PDT Partners sold 136,192 Novo Nordisk shares in Q3 2015, an estimated $3.73M.
  • PDT Partners first reported a position in Novo Nordisk in Q3 2013 and held it in 3 quarters.
  • PDT Partners's Novo Nordisk position peaked at $3.73M in Q2 2015.
  • 525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.